Boya Bio-pharmaceutical Group Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Boya Bio-pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Tianjin Ringpu Bio-Technology Co Ltd
sales of 969.68 million Chinese Renmimbi [US$147.50 million]
of which 63%
was Veterinary Biological Products),
Beijing SL Pharmaceutical Co Ltd
(1.01 billion Chinese Renmimbi [US$153.61 million]
of which 98%
was Pharmaceuticals Industry), and
Zhongyuan Union Cell & Gene Engineering Corp Ltd
(835.64 million Chinese Renmimbi [US$127.11 million]
of which 61%
was Scientific research service).
Boya Bio-pharmaceutical Group Co Ltd reported sales of 946.57 million Chinese Renmimbi (US$143.98 million)
December of 2016.
increase of 74.3%
versus 2015, when the company's sales were 543.10 million Chinese Renmimbi.
Sales at Boya Bio-pharmaceutical Group Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 381%).
Sales of Bio-Pharmaceuticals saw an increase
that was more than double the company's growth rate: sales were up
1,065.6% in 2016, from
18.56 million Chinese Renmimbi to 216.29 million Chinese Renmimbi.